Ocular toxicity secondary to paclitaxel in two lung cancer patients.
Tan
W W
WW
Department of Medical Oncology, University of Texas Health Science Center, San Antonio 78284, USA.
Walsh
T
T
D000230:Adenocarcinoma / Q000188:drug therapy; D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016190:Carboplatin / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced*
D000972:Antineoplastic Agents, Phytogenic; D016190:Carboplatin; D017239:Paclitaxel